Chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) patients meeting the diagnostic criteria of COPD; (2) stable patients with grade I or II disease; (3) aged 40 to 80 years; (4) those who did not participate in the clinical study of other interventions in the first 3 months; (5) voluntarily accept treatment and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) patients with acute exacerbation COPD; (2) stable patients with grade III or IV COPD; (3) pregnant and lactating women; (4) delirium, dementia and various mental diseases; (5) patients with severe cardiac dysfunction and hemodynamic instability; (6) patients with bronchiectasis, bronchial asthma, mobile tuberculosis, occlusive bronchiolitis, diffuse bronchiolitis; Combined with pulmonary embolism, pneumothorax and pleural effusion; Concomitant tumors; (7) neuromuscular diseases affecting respiratory motor function; (8) severe hepatorenal diseases, such as cirrhosis, portal hypertension and varicose bleeding; Dialysis and kidney transplantation; (9) long-term bedridden patients; (10) oral glucocorticoid administration within 1 month before inclusion; (11) congenital or acquired immunodeficiency; (12) participants in clinical trials of other drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The frequency and severity of acute exacerbations of COPD; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improved lung function;Quality of life;Patient satisfaction; | — |
Countries
China
Contacts
Tianjin University of Traditional Chinese Medicine